{"basic_info": {"ticker": "300294", "exchange": "XSHE", "bloomberg_ticker": "300294 CH Equity", "name": "BOYA BIO-PHARMACEUTICAL GR-A", "industry": "Biotechnology", "name_chinese_simplified": "博雅生物", "period": "2020", "market_value": 14546715648, "total_income": 1327906812, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 500146783, "business_income_over_total_income": 0.37664298313728356}, {"shariah_compliance": "unknown", "income": 827760027, "business_income_over_total_income": 0.6233570153565867}], "details": [{"business_activity_cn": "复大医药经销业务-人血白蛋白", "business_activity_en": "Forte pharmaceutical distribution business - human serum albumin", "income": 175222895, "business_income_over_total_income": 0.1319542105037413, "shariah_compliance": "compliant"}, {"business_activity_cn": "静注人免疫球蛋白", "business_activity_en": "Intravenous human immunoglobulin", "income": 161655049, "business_income_over_total_income": 0.12173674202071945, "shariah_compliance": "compliant"}, {"business_activity_cn": "人血白蛋白", "business_activity_en": "Human serum albumin", "income": 163268839, "business_income_over_total_income": 0.12295203061282285, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 179893, "business_income_over_total_income": 0.00013547110262131858, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 827580134, "business_income_over_total_income": 0.6232215442539654, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.010814614838435613, "shariah_compliance": "compliant", "amount_over_market_value": 0.010814614838435613}]}